Anticancer Research

Edit Your Profile

Anticancer Research Journal

publication venue for

Mosquitoes Exposed to Sunlight in Florida Are Capable of Making Vitamin D3. 42:5091-5094. 2022
Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing. 39:4023-4030. 2019
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis. 39:2911-2918. 2019
Vincristine-induced Blindness: A Case Report and Review of Literature. 34:6731-6733. 2014
Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer. 27:3801-3806. 2007
Rin1 is a negative regulator of the IL3 receptor signal transduction pathways. 26:905-916. 2006
Differential effect of camptothecin treatment on topoisomerase II alpha expression in ML-1 and HL-60 leukemia cell lines. 20:4183-4188. 2000
Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents. 18:3421-3426. 1998
Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. 18:713-718. 1998
The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter. 18:719-725. 1998
Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy. 17:811-813. 1997
Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. 22:1615-1627.
Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms. 19:5079-5085.
THE EFFECT OF ESTROGENS AND MEDROXYPROGESTERONE ACETATE ON THE UPTAKE OF CYTOTOXIC DRUGS BY MCF-7 BREAST-CANCER CELLS. 12:533-536.
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients. 18:1345-1349.

International Standard Serial Number (ISSN)

0250-7005

Electronic International Standard Serial Number (EISSN)

1791-7530